|
1
|
Siegel R, DeSantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Balaguer F, Moreira L, Lozano JJ, Link A,
Ramirez G, Shen Y, Cuatrecasas M, Arnold M, Meltzer SJ, Syngal S,
et al: Colorectal cancers with microsatellite instability display
unique miRNA profiles. Clin Cancer Res. 17:6239–6249. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lynch HT, Lynch PM, Lanspa SJ, Snyder CL,
Lynch JF and Boland CR: Review of the Lynch syndrome: History,
molecular genetics, screening, differential diagnosis and
medicolegal ramifications. Clin Genet. 76:1–18. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lynch HT, Boland CR, Gong G, Shaw TG,
Lynch PM, Fodde R, Lynch JF and de la Chapelle A: Phenotypic and
genotypic heterogeneity in the Lynch syndrome: Diagnostic,
surveillance and management implications. Eur J Hum Genet.
14:390–402. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luschka H: Ueber polypöse Vegetationen der
gesammten Dickdarmschleimhaut. Virchow's Arch f path Anat.
20:133–142. 1861. View Article : Google Scholar
|
|
7
|
Jass JR: Heredity and DNA methylation in
colorectal cancer. Gut. 56:154–155. 2007.PubMed/NCBI
|
|
8
|
Qian CN, Furge KA, Knol J, Huang D, Chen
J, Dykema KJ, Kort EJ, Massie A, Khoo SK, Vanden Beldt K, et al:
Activation of the PI3K/AKT pathway induces urothelial carcinoma of
the renal pelvis: Identification in human tumors and confirmation
in animal models. Cancer Res. 69:8256–8264. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
van Engeland M, Derks S, Smits KM, Meijer
GA and Herman JG: Colorectal cancer epigenetics: Complex
simplicity. J Clin Oncol. 29:1382–1391. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Murphy ME: Polymorphic variants in the p53
pathway. Cell Death Differ. 13:916–920. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wettenhall JM and Smyth GK: limmaGUI: A
graphical user interface for linear modeling of microarray data.
Bioinformatics. 20:3705–3706. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J Roy Stat Soc B. 57:289–300. 1995.
|
|
13
|
Leidinger P, Keller A, Borries A,
Reichrath J, Rass K, Jager SU, Lenhof HP and Meese E:
High-throughput miRNA profiling of human melanoma blood samples.
BMC Cancer. 10:2622010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dweep H, Sticht C, Pandey P and Gretz N:
miRWalk-database: Prediction of possible miRNA binding sites by
‘walking’ the genes of three genomes. J Biomed Inform. 44:839–847.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang X and El Naqa IM: Prediction of both
conserved and nonconserved microRNA targets in animals.
Bioinformatics. 24:325–332. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky N: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Betel D, Koppal A, Agius P, Sander C and
Leslie C: Comprehensive modeling of microRNA targets predicts
functional non-conserved and non-canonical sites. Genome Biol.
11:R902010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hulsegge I, Kommadath A and Smits MA:
Globaltest and GOEAST: Two different approaches for Gene ontology
analysis. BMC Proc. 3(Suppl 4): S102009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
da Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wingender E, Dietze P, Karas H and Knüppel
R: TRANSFAC: A database on transcription factors and their DNA
binding sites. Nucleic Acids Res. 24:238–241. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen JS, Hung WS, Chan HH, Tsai SJ and Sun
HS: In silico identification of oncogenic potential of fyn-related
kinase in hepatocellular carcinoma. Bioinformatics. 29:420–427.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao M, Sun J and Zhao Z: TSGene: A web
resource for tumor suppressor genes. Nucleic Acids Res. 41(Database
issue): D970–D976. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boudreault F, Pinilla M, Kho A, Baron R
and Tschumperlin D: Metallothionein is a stretch-induced gene that
confers protection during mechanical ventilation. Technology.
1:32011.
|
|
27
|
Günther V, Lindert U and Schaffner W: The
taste of heavy metals: Gene regulation by MTF-1. Biochim Biophys
Acta. 1823:1416–1425. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Saini N, Georgiev O and Schaffner W: The
parkin mutant phenotype in the fly is largely rescued by
metal-responsive transcription factor (MTF-1). Mol Cell Biol.
31:2151–2161. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Günther V, Davis AM, Georgiev O and
Schaffner W: A conserved cysteine cluster, essential for
transcriptional activity, mediates homodimerization of human
metal-responsive transcription factor-1 (MTF-1). Biochim Biophys
Acta. 1823:476–483. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arriaga JM, Levy EM, Bravo AI, Bayo SM,
Amat M, Aris M, Hannois A, Bruno L, Roberti MP, Loria FS, et al:
Metallothionein expression in colorectal cancer: Relevance of
different isoforms for tumor progression and patient survival. Hum
Pathol. 43:197–208. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Morandi L, de Biase D, Visani M, Monzoni
A, Tosi A, Brulatti M, Turchetti D, Baccarini P, Tallini G and
Pession A: T ([20]) repeat in the 3′-untranslated region of the
MT1X gene: A marker with high sensitivity and specificity to detect
microsatellite instability in colorectal cancer. Int J Colorectal
Dis. 27:647–656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Constant S, Huang S, Wiszniewski L and Mas
C: Colon cancer: Current treatments and preclinical models for the
discovery and development of new therapies. Drug Discovery.
El-Shemy HA: InTech. (Rijeka). 433–458. 2013.PubMed/NCBI
|
|
33
|
Ghaleb AM and Yang VW: The pathobiology of
Krüppel-like factors in colorectal cancer. Current Colorectal
Cancer Rep. 4:59–64. 2008. View Article : Google Scholar
|
|
34
|
Rowland BD, Bernards R and Peeper DS: The
KLF4 tumour suppressor is a transcriptional repressor of p53 that
acts as a context-dependent oncogene. Nat Cell Biol. 7:1074–1082.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shao J, Yang VW and Sheng H: Prostaglandin
E2 and Krüppel-like transcription factors synergistically induce
the expression of decay-accelerating factor in intestinal
epithelial cells. Immunology. 125:397–407. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dang DT, Chen X, Feng J, Torbenson M, Dang
LH and Yang VW: Overexpression of Krüppel-like factor 4 in the
human colon cancer cell line RKO leads to reduced tumorigenecity.
Oncogene. 22:3424–3430. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Saunders IW, Ross J, Macrae F, Young GP,
Blanco I, Brohede J, Brown G, Brookes D, Lockett T, Molloy PL, et
al: Evidence of linkage to chromosomes 10p15.3-p15.1, 14q24.3-q31.1
and 9q33.3-q34.3 in non-syndromic colorectal cancer families. Eur J
Hum Genet. 20:91–96. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Miyaki M, Yamaguchi T, Iijima T, Funata N
and Mori T: Difference in the role of loss of heterozygosity at
10p15 (KLF6 locus) in colorectal carcinogenesis between sporadic
and familial adenomatous polyposis and hereditary nonpolyposis
colorectal cancer patients. Oncology. 71:131–135. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Namikawa K, Honma M, Abe K, Takeda M,
Mansur K, Obata T, Miwa A, Okado H and Kiyama H: Akt/protein kinase
B prevents injury-induced motoneuron death and accelerates axonal
regeneration. J Neurosci. 20:2875–2886. 2000.PubMed/NCBI
|
|
40
|
Leu CM: Nck, a missing adaptor between the
B-cell receptor complex and the BCAP/PI3K/Akt pathway. Cell Mol
Immunol. 11:120–122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liang L, Li X, Zhang X, Lv Z, He G, Zhao
W, Ren X, Li Y, Bian X, Liao W, et al: MicroRNA-137, an HMGA1
target, suppresses colorectal cancer cell invasion and metastasis
in mice by directly targeting FMNL2. Gastroenterology.
144:624.e4–635.e4. 2013. View Article : Google Scholar
|
|
42
|
Yang H, Zheng W, Zhao W, Guan C and An J:
Roles of miR-590-5p and miR-590-3p in the development of
hepatocellular carcinoma. Nan Fang Yi Ke Da Xue Xue Bao.
33:804–811. 2013.(In Chinese). PubMed/NCBI
|
|
43
|
Ekstrand AI, Jönsson M, Lindblom A, Borg A
and Nilbert M: Frequent alterations of the PI3K/AKT/mTOR pathways
in hereditary nonpolyposis colorectal cancer. Fam Cancer.
9:125–129. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Laplante M and Sabatini DM: mTOR signaling
in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wullschleger S, Loewith R and Hall MN: TOR
signaling in growth and metabolism. Cell. 124:471–484. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gulhati P, Cai Q, Li J, Liu J, Rychahou
PG, Qiu S, Lee EY, Silva SR, Bowen KA, Gao T and Evers BM: Targeted
inhibition of mammalian target of rapamycin signaling inhibits
tumorigenesis of colorectal cancer. Clin Cancer Res. 15:7207–7216.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Johnson SM, Gulhati P, Rampy BA, Han Y,
Rychahou PG, Doan HQ, Weiss HL and Evers BM: Novel expression
patterns of PI3K/Akt/mTOR signaling pathway components in
colorectal cancer. J Am Coll Surg. 210:767–776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Schneider G and Schmid RM: Genetic
alterations in pancreatic carcinoma. Mol Cancer. 2:152003.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Roy HK, Olusola BF, Clemens DL, Karolski
WJ, Ratashak A, Lynch HT and Smyrk TC: AKT proto-oncogene
overexpression is an early event during sporadic colon
carcinogenesis. Carcinogenesis. 23:201–205. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mellinghoff IK and Sawyers CL: TORward
AKTually useful mouse models. Nat Med. 10:579–580. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bi X, Lin Q, Foo TW, Joshi S, You T, Shen
HM, Ong CN, Cheah PY, Eu KW and Hew CL: Proteomic analysis of
colorectal cancer reveals alterations in metabolic pathways:
Mechanism of tumorigenesis. Mol Cell Proteomics. 5:1119–1130. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Baba Y, Nosho K, Shima K, Irahara N, Chan
AT, Meyerhardt JA, Chung DC, Giovannucci EL, Fuchs CS and Ogino S:
HIF1A overexpression is associated with poor prognosis in a cohort
of 731 colorectal cancers. Am J Pathol. 176:2292–2301. 2010.
View Article : Google Scholar : PubMed/NCBI
|
